ACT-Candesartan 4mg tablets (2018-11-23)
- Starting date:
- November 23, 2018
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-68540
Recalled Products
ACT-Candesartan 4mg tablets
Reason
An impurity out of specification is expected near the expiry date in the affected lots.
Depth of distribution
Wholesalers, Retailers
Affected products
ACT-Candesartan 4mg tablets
DIN, NPN, DIN-HIM
DIN 02376520Dosage form
Tablets
Strength
Candesartan Cilexetil 4mg
Lot or serial number
K49247, K49268, K49269, K50970, K50973, K51008
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA